Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):e12–e22. doi: 10.1097/QAI.0000000000002422

Table 3.

Results of multiple linear regression examining the combined effects of HIV and METH on CSF norepinephrine

Parameter beta (SE) 95% CI p
HIVa 0.75 (0.21) 0.34, 1.16 <0.001
METHb 0.45 (0.19) 0.08, 0.81 0.017
HIV x METH −0.96 (0.26) −1.47, –0.45 <0.001
Lifetime MDD 0.28 (0.13) 0.02, 0.54 0.035
Antidepressant use −0.34 (0.14) −0.62, –0.06 0.017
White (vs. not White) 0.22 (0.13) −0.04, 0.48 0.099
a

Represents effect of HIV+ vs. HIV- in METH- individuals only (reference group)

b

Represents effect of METH+ vs. METH- in HIV- individuals only (reference group)